Form 4: Arteris CFO Sells Shares Under Pre-Arranged 10b5-1 Trading Plan
Insider Transaction Report
Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, sold a total of 11,276 shares of common stock over two days in June 2025, pursuant to a pre-arranged 10b5-1 trading plan.
Summary
- Nicholas B. Hawkins, the Vice President and Chief Financial Officer of Arteris, Inc. (AIP), reported sales of the company's common stock.
- On June 25, 2025, Mr. Hawkins sold 5,638 shares of common stock at a price of $9.50 per share.
- On June 26, 2025, an additional 5,638 shares of common stock were sold at a price of $9.75 per share.
- These transactions were executed under a Rule 10b5-1 trading plan, which was adopted by Mr. Hawkins on May 20, 2024.
- Following these reported transactions, Mr. Hawkins beneficially owns 150,661 shares of Arteris, Inc. common stock directly.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the reported sales were conducted under a pre-arranged 10b5-1 trading plan, which typically indicates a scheduled liquidity event rather than a change in management's outlook on the company's prospects.
Positives
- The sales were conducted under a Rule 10b5-1 trading plan, which indicates the transactions were pre-scheduled and not based on immediate, non-public information, enhancing transparency and reducing the perception of opportunistic insider trading.
Negatives
- Insider sales, even when pre-planned, can sometimes be perceived negatively by the market as they reduce the insider's direct ownership stake in the company.
Future Outlook
NA
Industry Context
This SEC Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | Nicholas B. Hawkins adopted a Rule 10b5-1 trading plan on May 20, 2024, which pre-arranges the sale of securities to comply with insider trading regulations. | 2024-05-20 | This plan enhances corporate governance by providing a legal affirmative defense against insider trading allegations, as sales are scheduled in advance and not based on material non-public information. |
Stakeholder Impact
- Shareholders: May observe a reduction in insider ownership, which could be interpreted in various ways, though the 10b5-1 plan mitigates concerns about opportunistic selling.
Key Dates
| Date | Description |
|---|---|
| 2024-05-20 | Date the Rule 10b5-1 trading plan was adopted by Nicholas B. Hawkins. |
| 2025-06-25 | Date Nicholas B. Hawkins sold 5,638 shares of common stock at $9.50 per share. |
| 2025-06-26 | Date Nicholas B. Hawkins sold 5,638 shares of common stock at $9.75 per share and the filing date of the Form 4. |
Recommendation
holdKeywords
Arteris Inc., AIP, Form 4, Insider Trading, Stock Sale, Nicholas B. Hawkins, 10b5-1 Plan, CFO, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.